EQT Group ac­quires VC firm in $500M+ deal; Sanofi se­lects IPO lead­ers for 2022 API spin­out — re­port

Pri­vate in­vest­ment group EQT an­nounced an agree­ment this morn­ing to buy out Life Sci­ence Part­ners, a Eu­ro­pean VC firm with more than $2.5 bil­lion un­der man­age­ment.

While de­tails are not com­plete, EQT agreed to $520 mil­lion up­front — 25% in cash and 75% in new EQT shares. There is al­so po­ten­tial for a $29 mil­lion earn-out pay­ment, ac­cord­ing to an EQT state­ment.

Michael Bauer, Part­ner and Co-Head of EQT’s Glob­al Health­care sec­tor team, said, “We are tru­ly ex­cit­ed about the op­por­tu­ni­ty to join forces with LSP and form EQT Life Sci­ences. The EQT and LSP teams have com­ple­men­tary skill sets, and the com­bi­na­tion will al­low us to sup­port health­care com­pa­nies and their man­age­ment teams in a unique way.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER